miR-205-5p、PDCD5、Beclin1在子宫内膜癌组织中的表达及相关性研究

doi:10.3969/j.issn.1007-3205.2022.07.011

河北医科大学学报 ›› 2022, Vol. 43 ›› Issue (7): 796-800,816.doi: 10.3969/j.issn.1007-3205.2022.07.011

miR-205-5p、PDCD5、Beclin1在子宫内膜癌组织中的表达及相关性研究

1.河北省保定市第二中心医院妇科,河北保定 072750;2.河北省石家庄市第八医院内科,河北石家庄 050051;
3.河北省第八人民医院外一科,河北石家庄 050011

出版日期:2022-07-25 发布日期:2022-07-26
作者简介:刘秋颖（1984-），女，河北定兴人，河北省保定市第二中心医院主治医师，医学硕士，从事妇科疾病诊治研究。
基金资助:
河北省医学科学研究课题计划（20200265）

Expression of miR-205-5p, PDCD5 and Beclin1 in endometrial cancer tissues and their correlation

1.Department of Gynaecology, the Second Central Hospital of Baoding City, Hebei Province, Baoding
072750, China; 2.Department of Internal Medicine, the Eighth Hospital of Shijiazhuang City,
Hebei Province, Shijiazhuang 050051, China; 3.The First Department of General Surgery,
the Eighth People's Hospital of Hebei Province, Shijiazhuang 050011, China

Online:2022-07-25 Published:2022-07-26

摘要/Abstract

摘要： 目的研究子宫内膜癌组织中微小RNA(microRNA miR-205-5p)、程序性细胞坏死因子5（programmed cell necrosis factor 5,PDCD5）、Beclin1的表达情况及三者之间的相关性。
方法选择75例子宫内膜癌组织和距离癌组织边缘5 cm癌旁组织。通过免疫组织化学、实时荧光定量法检测miR-205-5p、PDCD5、Beclin1的表达情况，分析miR-205-5p、PDCD5、Beclin1的相关性及对子宫内膜癌的诊断价值。
结果癌组织中miR-205-5p表达高于癌旁组织，PDCD5、Beclin1表达低于癌旁组织（P＜0.05）。不同组织学分级、临床分期、淋巴结转移、肌层浸润子宫内膜癌患者miR-205-5p、PDCD5、Beclin1表达差异有统计学意义（P＜0.05），Ⅲ~Ⅳ期、中低分化、有淋巴结转移、≥1/2肌层浸润子宫内膜癌患者miR-205-5p表达升高，PDCD5、Beclin1表达降低，差异有统计学意义（P＜0.05）。不同年龄、病理类型子宫内膜癌患者miR-205-5p、PDCD5、Beclin1表达差异无统计学意义（P＞0.05）。miR-205-5p、PDCD5之间呈负相关，miR-205-5p、Beclin1之间呈负相关，PDCD5、Beclin1之间呈正相关（P＜0.05）。三项联合诊断子宫内膜癌的价值高于miR-205-5p、PDCD5、Beclin1单项诊断（P＜0.05）。
结论 miR-205-5p表达升高，PDCD5、Beclin1表达降低对子宫内膜癌的发展起到了促进作用，参与子宫内膜癌的演变进程，临床可根据上述指标对子宫内膜癌进行预测。

关键词: 子宫内膜肿瘤, miR-205-5p, PDCD5, Beclin1

Abstract: Objective To explore the expression of microRNA-205-5p(miR-205-5p), programmed cell necrosis factor 5(PDCD5), and Beclin1 in endometrial cancer tissues and their correlation.
Methods In total, 75 cases of endometrial cancer tissues and adjacent tissues 5 cm away from the edge of the cancerous tissue of endometrial cancer were selected. The expressions of miR-205-5p, PDCD5, and Beclin1 were detected by immunohistochemistry and real-time fluorescence quantification methods, and the correlation of MiR-205-5p, PDCD5 and Beclin1 and their diagnostic value for endometrial cancer were analyzed.
Results The expression of miR-205-5p in cancer tissues was higher than that in adjacent tissues, while the expression of PDCD5 and Beclin1 were lower than that in adjacent tissues(P＜0.05). The expressions of miR-205-5p, PDCD5 and Beclin1 in endometrial cancer patients with different histological grade, clinical stage, lymph node metastasis and muscle invasion were significantly different(P＜0.05). The expressions of miR-205-5p were increased in endometrial cancer patients with stage Ⅲ-Ⅳ, moderate-to-low differentiation, lymph node metastasis and muscle invasion≥1/2 , while the expression of PDCD5 and Beclin1 were decreased, and the difference was statistically significant(P＜0.05). There were no significant differences in the expressions of miR-205-5p, PDCD5 and Beclin1 in endometrial cancer patients with different ages and pathological types(P＞0.05). There was negative correlation between miR-205-5p and PDCD5, negative correlation between miR-205-5p and Beclin1, and positive correlation between PDCD5 and Beclin1(P＜0.05). The value of combined detection of the three in the diagnosis of endometrial cancer was higher than that of miR-205-5p, PDCD5 and Beclin1 alone(P＜0.05).
Conclusion The increased expression of miR-205-5p and the decreased expression of PDCD5 and Beclin1 promote the development of endometrial cancer and participate in the evolution of endometrial cancer. The endometrial cancer can be predicted in clinical practice according to the above indicators.

Key words: endometrial neoplasms, microRNA-205-5p, programmed cell necrosis factor 5, Beclin1

刘秋颖, 李晓妍, 张亚云, 张凤. miR-205-5p、PDCD5、Beclin1在子宫内膜癌组织中的表达及相关性研究 [J]. 河北医科大学学报, 2022, 43(7): 796-800,816.

LIU Qiu-ying, LI Xiao-yan, ZHANG Ya-yun, ZHANG Feng. Expression of miR-205-5p, PDCD5 and Beclin1 in endometrial cancer tissues and their correlation [J]. Journal of Hebei Medical University, 2022, 43(7): 796-800,816.

[1]	黄雨农，姚小刚，赵明，陈静. 磁共振与超声在子宫内膜癌诊断中的对比分析#br#[J]. 河北医科大学学报, 2020, 41(9): 1097-1100.
[2]	张晓欲1，左金玲2，李桂荣3. 子宫内膜癌合并输卵管癌原发性双癌病例分析#br#[J]. 河北医科大学学报, 2020, 41(3): 342-345.
[3]	马阳，王蕊，纪晓坤，吴娟，杜芸，王珩. EGFR突变对肺腺癌细胞自噬活性及LC3、Beclin1基因表达的影响[J]. 河北医科大学学报, 2019, 40(9): 1072-1075.
[4]	李美艳. 宫内膜癌中VM、VEGF对PLN转移的影响及预后分析[J]. 河北医科大学学报, 2018, 38(8): 938-942.
[5]	胡美丽;李利;王晓玲;康山. 三氧化二砷抑瘤机制及对荷瘤裸鼠不良反应的研究[J]. , 2015, 36(11): 1276-1276.
[6]	李超;赵慧尔;王翠. 子宫内膜癌患者术前分段诊断性刮宫术与术后病理诊断的比较[J]. , 2014, 35(9): 1029-1029.
[7]	胡美丽;李利;王晓玲;康山. 三氧化二砷对人子宫内膜癌移植瘤的影响[J]. , 2014, 35(11): 1281-1281.
[8]	赵文波;樊爱军;楼正青;王育瑛. 子宫内膜癌端粒酶催化亚单位表达与DNA含量的相关性研究[J]. , 2013, 34(6): 674-674.
[9]	石莉;高秀泽;李利. GST-π、NQO1在子宫内膜癌组织中的表达及意义[J]. , 2012, 33(9): 1015-1015.
[10]	牛书怀;樊晓妹;宋藏珠;李魁秀;房朝辉;刘红. 原发子宫内膜小细胞癌2例[J]. , 2012, 33(4): 0-0.
[11]	赖世平. p16、EGFR在子宫内膜癌组织中的表达及临床意义[J]. , 2012, 33(3): 334-334.
[12]	王瑾;笪纪平;徐培培;李雪静;程建新;李利. 细胞色素P4501B1在子宫内膜癌组织中的表达与ER相关[J]. , 2012, 33(11): 1241-1241.
[13]	常迎香;陈红青;南凤艳;郝淑维;孙菊英. 内皮素和血管内皮生长因子在子宫内膜腺癌中的研究[J]. , 2011, 32(4): 413-413.
[14]	刘淳;杨蕴;刘双静;李雅钗;范秀华. 子宫内膜癌中ER、PR、MK、VEGF的表达及与病理特征的关系[J]. , 2010, 31(9): 1072-1072.
[15]	刘淳;刘双静;黄向华;李雅钗. 血管内皮生长因子及中期因子在子宫内膜癌中的表达及意义[J]. , 2010, 31(7): 786-786.

miR-205-5p、PDCD5、Beclin1在子宫内膜癌组织中的表达及相关性研究

Expression of miR-205-5p, PDCD5 and Beclin1 in endometrial cancer tissues and their correlation

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价